Indivior (NasdaqGS:INDV): Fresh Clinical Data Prompts a Closer Look at Current Valuation [Yahoo! Finance]
Indivior PLC - Ordinary Shares (INDV)
Company Research
Source: Yahoo! Finance
treatment, SUBLOCADE, is linked with higher patient retention compared to standard protocols, particularly among fentanyl users. See our latest analysis for Indivior. Indivior's clinical milestone has arrived during a period of remarkable momentum. The company's 1-year total shareholder return sits at an impressive 209%, while its share price has more than doubled year-to-date. Recent advances in opioid use disorder treatment and a string of positive trial results have helped turbocharge sentiment, suggesting that investors are reassessing both Indivior's growth runway and its role in addressing urgent healthcare needs. If new developments in the healthcare space interest you, it might be time to explore fresh opportunities in the sector. See the full list for free. After such rapid share price gains and positive clinical advances, is Indivior's valuation still attractive, or is the market already reflecting future growth expectations in its stock price? Price-to-Earnings of
Show less
Read more
Impact Snapshot
Event Time:
INDV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INDV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INDV alerts
High impacting Indivior PLC - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
INDV
News
- Addex Therapeutics Ltd (ADXN) Q3 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Indivior (NASDAQ:INDV) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.MarketBeat
- A Fresh Look at Indivior (INDV) Valuation Following Recent Share Price Surge [Yahoo! Finance]Yahoo! Finance
- Indivior Concludes Legacy U.S. Department of Justice Matter [Yahoo! Finance]Yahoo! Finance
- Indivior Concludes Legacy U.S. Department of Justice MatterPR Newswire
INDV
Earnings
- 10/30/25 - Beat
INDV
Sec Filings
- 11/20/25 - Form 8-K
- 11/14/25 - Form 8-K
- 11/13/25 - Form SCHEDULE
- INDV's page on the SEC website